Example: Heart Attack
Clinical Trials on Mucopolysaccharidosis II
Total 66 results
-
NCT04571970Not yet recruitingConditions: Mucopolysaccharidosis Type II (MPS II)
-
NCT04539340RecruitingA Multi-cohort Study of the Tolerance, Safety, and Pharmacokinetics of GNR-055 in Healthy VolunteersConditions: Mucopolysaccharidosis Type II; Metabolic Diseases
-
NCT04532047Not yet recruitingConditions: MPS I; MPS II; MPS IVA; MPS VI; Mps VII; Gaucher Disease, Type 2; Gaucher Disease, Type 3; Pompe Disease Infantile-Onset; Wolman Disease
-
NCT04528355RecruitingConditions: Primary Immunodeficiency (PID); Congenital Bone Marrow Failure Syndromes; Inherited Metabolic Disorders (IMD); Hereditary Anemias; Inflammatory Conditions
-
NCT04348136Enrolling by invitationConditions: Mucopolysaccharidosis II
-
NCT04251026RecruitingConditions: Mucopolysaccharidosis II
-
NCT04227600Not yet recruitingConditions: Mucopolysaccharidosis I
-
NCT04201405RecruitingConditions: Mucopolysaccharidosis Type IIIA
-
NCT04007536RecruitingConditions: Hunter Syndrome
-
NCT03920540RecruitingConditions: Hunter Syndrome
-
NCT03708965Enrolling by invitationConditions: Mucopolysaccharidosis II
-
NCT03582449CompletedConditions: Hunter Syndrome
-
NCT03580083RecruitingConditions: Mucopolysaccharidosis Type I (MPS I)
-
NCT03568175Active, not recruitingConditions: Mucopolysaccharidosis II
-
NCT03566043RecruitingConditions: Mucopolysaccharidosis Type II (MPS II)
-
NCT03529786Active, not recruitingConditions: Mucopolysaccharidosis II
-
NCT03488394RecruitingConditions: Mucopolysaccharidosis IH
-
NCT03359213CompletedConditions: Mucopolysaccharidosis II
-
NCT03333200RecruitingConditions: MLD; Krabbe Disease; ALD; MPS I; MPS II; MPS III; Vanishing White Matter Disease; GM3 Gangliosidosis; PKAN; Tay-Sachs Disease; NP Deficiency; Osteopetrosis; Alpha-Mannosidosis; Sandhoff Disease; Niemann-Pick Diseases; MPS IV; Gaucher Disease; GAN; GM1 Gangliosidoses; Morquio Disease; S-Adenosylhomocysteine Hydrolase Deficiency; Batten Disease; Pelizaeus-Merzbacher Disease; Leukodystrophy; Lysosomal Storage Diseases; Purine Nucleoside Phosphorylase Deficiency; Multiple Sulfatase Deficiency Disease
-
NCT03315182RecruitingConditions: Mucopolysaccharidosis Type 3 B
-
NCT03292887RecruitingConditions: Hunter Syndrome
-
NCT03173521RecruitingConditions: Mucopolysaccharidosis Type VI
-
NCT03161171CompletedConditions: Mucopolysaccharidosis Type I; Mucopolysaccharidosis Type II; Mucopolysaccharidosis Type III; Behavior Disorders; Coping Behavior
-
NCT03153319RecruitingConditions: Mucopolysaccharidosis I; Mucopolysaccharidosis II
-
NCT03128593CompletedConditions: Mucopolysaccharidosis II
-
NCT03041324Active, not recruitingConditions: Mucopolysaccharidosis II; MPS II
-
NCT02716246RecruitingConditions: MPS IIIA; Sanfilippo Syndrome; Sanfilippo A; Mucopolysaccharidosis III
-
NCT02663024Unknown statusConditions: Mucopolysaccharidosis II
-
NCT02455622Active, not recruitingConditions: Hunter Syndrome
-
NCT02437253CompletedConditions: Mucopolysaccharidosis Type I; Mucopolysaccharidosis Type II; Mucopolysaccharidosis Type VI
-
NCT02412787Active, not recruitingConditions: Hunter Syndrome
-
NCT02324049CompletedConditions: Mucopolysaccharidosis IIIB
-
NCT02262338CompletedConditions: Mucopolysaccharidosis II
-
NCT02254863RecruitingConditions: Adrenoleukodystrophy; Batten Disease; Mucopolysaccharidosis II; Leukodystrophy, Globoid Cell; Leukodystrophy, Metachromatic; Neimann Pick Disease; Pelizaeus-Merzbacher Disease; Sandhoff Disease; Tay-Sachs Disease; Brain Diseases, Metabolic, Inborn; Alpha-Mannosidosis; Sanfilippo Mucopolysaccharidoses
-
NCT02171104RecruitingConditions: Mucopolysaccharidosis Disorders; Hurler Syndrome; Hunter Syndrome; Maroteaux Lamy Syndrome; Sly Syndrome; Alpha-Mannosidosis; Fucosidosis; Aspartylglucosaminuria; Glycoprotein Metabolic Disorders; Sphingolipidoses; Recessive Leukodystrophies; Globoid Cell Leukodystrophy; Metachromatic Leukodystrophy; Niemann-Pick B; Niemann-Pick C Subtype 2; Sphingomyelin Deficiency; Peroxisomal Disorders; Adrenoleukodystrophy With Cerebral Involvement; Zellweger Syndrome; Neonatal Adrenoleukodystrophy; Infantile Refsum Disease; Acyl-CoA Oxidase Deficiency; D-Bifunctional Enzyme Deficiency; Multifunctional Enzyme Deficiency; Alpha-methylacyl-CoA Racmase Deficiency; Mitochondrial Neurogastrointestingal Encephalopathy; Severe Osteopetrosis; Hereditary Leukoencephalopathy With Axonal Spheroids (HDLS; CSF1R Mutation); Inherited Metabolic Disorders
-
NCT02095015TerminatedConditions: Mucopolysaccharidosis (MPS)
-
NCT02060526CompletedConditions: Sanfilippo Syndrome
-
NCT02055118CompletedConditions: Hunter Syndrome
-
NCT02044692Unknown statusThe Long-term Safety Study of Idursulfase-beta in Hunter Syndrome(Mucopolysaccharidosis II) PatientsConditions: Hunter Syndrome
-
NCT01962415RecruitingConditions: Primary Immunodeficiency (PID); Congenital Bone Marrow Failure Syndromes; Inherited Metabolic Disorders (IMD); Hereditary Anemias; Inflammatory Conditions
-
NCT01938014CompletedConditions: Mucopolysaccharidosis Type I (MPS I); Mucopolysaccharidosis Type II (MPS II); Mucopolysaccharidosis Type III (MPS III); Mucopolysaccharidosis Type VI (MPS VI); Krabbe Disease
-
NCT01870375CompletedConditions: Mucopolysaccharidosis Type I; Mucopolysaccharidosis Type II; Mucopolysaccharidosis Type VI; Mucopolysaccharidosis Type IV; Mucopolysaccharidosis Type VII
-
NCT01822184CompletedConditions: Mucopolysaccharidosis (MPS); Hunter Syndrome
-
NCT01675674TerminatedConditions: Mucopolysaccharidoses; Mucopolysaccharidosis I; Mucopolysaccharidosis II; Mucopolysaccharidosis IV; Mucopolysaccharidosis VI
-
NCT01645189CompletedConditions: Hunter Syndrome
-
NCT01602601CompletedConditions: Mucopolysaccharidosis II
-
NCT01586871CompletedConditions: MPS I; MPS II; MPS VI; Mucopolysaccharidoses
-
NCT01521429CompletedConditions: Mucopolysaccharidoses
-
NCT01506141Active, not recruitingConditions: Hunter Syndrome
-
NCT01449240CompletedConditions: Hunter Syndrome